PYC Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 7, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	1,047	755	560	191	207	493
Market Cap Growth	68.02%	34.90%	192.66%	-7.47%	-58.06%	46.25%
Enterprise Value	927	708	536	175	165	438
Last Close Price	1.06	1.26	1.17	0.54	0.62	1.49
PS Ratio	50.93	32.15	25.38	12.10	12.89	160.37
PB Ratio	7.11	4.44	6.91	6.73	5.14	9.14
P/TBV Ratio	7.30	4.56	7.33	8.14	5.92	10.19
EV/Sales Ratio	45.11	30.12	24.29	11.10	10.26	142.63
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.01
Net Debt / Equity Ratio	-0.81	-0.89	-0.81	-0.54	-0.70	-0.94
Net Debt / EBITDA Ratio	2.33	2.88	1.73	0.67	2.06	2.77
Net Debt / FCF Ratio	1.81	2.89	1.69	0.61	1.27	4.10
Asset Turnover	0.18	0.17	0.34	0.38	0.31	0.07
Quick Ratio	13.92	14.38	9.32	3.79	8.93	15.68
Current Ratio	13.96	14.41	9.40	3.79	8.95	15.71
Return on Equity (ROE)	-47.55%	-40.64%	-69.61%	-68.05%	-30.37%	-44.29%
Return on Assets (ROA)	-28.68%	-24.42%	-37.83%	-35.49%	-17.29%	-26.20%
Return on Capital Employed (ROCE)	-35.20%	-31.40%	-47.30%	-81.50%	-34.90%	-34.30%
Earnings Yield	-4.54%	-6.66%	-6.74%	-11.91%	-6.71%	-3.60%
FCF Yield	-6.32%	-6.96%	-6.95%	-13.02%	-10.72%	-2.51%
Buyback Yield / Dilution	-27.58%	-27.16%	-22.59%	-0.93%	-2.89%	-12.58%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.